Skip to main content

Stereotaxis, Inc.

STXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001289340

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Stereotaxis, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of STXS: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1153108−4
Shares42.9M69.0K43.1M+196.8K (+0.5%)
Value$79.0M$127.0K$74.1M−$4.80M (−6.1%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Stereotaxis, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to STXS in Q2 2026
InstitutionSharesValue% of portfolio
Citadel Advisors LLC183,087$314.9K0.00%
R Squared Ltd13,727$23.6K0.01%
Cerity Partners LLC13,572$23.3K0.00%
Quadrature Capital Ltd10,706$18.4K0.00%
Pasadena Private Wealth, LLC10,000$17.2K0.00%
Simplex Trading, LLC2,880$4.95K0.00%
SRS Capital Advisors, Inc.1,420$2.44K0.00%
Massmutual Trust Co FSB467$8030.00%
Rossby Financial, LCC312$5370.00%
Fortitude Family Office, LLC84$1440.00%
Clearstead Advisors, LLC9$160.00%
JPL Wealth Management, LLC8$140.00%

Sold out (16)

Institutions that held Stereotaxis, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (3)

Institutions that held Stereotaxis, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STXS in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
TCFG Wealth Management, LLC64,015$117.8K
CWM, LLC4,988$9.18K
Sunbelt Securities, Inc.43$79